Farther Finance Advisors’s Soleno Therapeutics SLNO Stock Holding History

Farther Finance Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-164	Closed	-$6.07K	–	6098
2026 Q1	$6.07K	Sell	164 -1	-0.6%	-$39	﹤0.01%	4394
2025 Q4	$7.64K	Buy	165 +81	+96%	+$4.44K	﹤0.01%	4087
2025 Q3	$5.68K	Buy	84 +81	+2,700%	+$6K	﹤0.01%	3707
2025 Q2	$251	Buy	+3	New	+$225	﹤0.01%	4169

Farther Finance Advisors's SLNO Position: Q2 2026 in Review

Farther Finance Advisors sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 164 shares — an estimated $6.07K sold.

Farther Finance Advisors first reported a position in SLNO in Q2 2025 and held it in 4 quarters. The position peaked at $7.64K in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Farther Finance Advisors reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 164 Soleno Therapeutics shares in Q2 2026, an estimated $6.07K.
Farther Finance Advisors first reported a position in Soleno Therapeutics in Q2 2025 and held it in 4 quarters.
Farther Finance Advisors's Soleno Therapeutics position peaked at $7.64K in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.